BofA Securities Raise PT on Kala Pharmaceuticals Inc. (KALA) to $16 on Eysuvius Potentail
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Kala Pharmaceuticals (NASDAQ: KALA) to $16.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
